Peter Kratzsch

USPTO Granted Patents = 11 (Patent Applications = 1)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 42(Granted Patents)

Location History:

Antdorf, DE (2005 - 2009)
Penzberg, DE (2009 - 2021)

Company Filing History:

6 out of 1,648

Roche Diagnostics Operations, Inc.

patents

3 out of 618

Roche Diabetes Care, Inc.

patents

2 out of 4,942

Hoffmann-la Roche Inc.

patents

4. 1 out of 480

Roche Diagnostics Gmbh

patents

where one patent can have more than one assignee

Years Active: 2005-2021

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11169146 - Activity assay for bond forming enzymes (2021-11-09),

2. 10704029 - Mutant 3-hydroxybutyrate dehydrogenase fromas well as methods and uses involving the same (2020-07-07),

3. 10508267 - Mutant 3-hydroxybutyrate dehydrogenase from alcaligenes faecalis as well as methods and uses involving the same (2019-12-17),

4. 10190182 - Methods for enzyme mediated polypeptide conjugation (2019-01-29),

5. 9840729 - Azo mediators and methods of use thereof (2017-12-12),

6. 7781196 - Thermostable mutants of pyrroloquinoline quinone dependent glucose dehydrogenase (2010-08-24),

7. 7732179 - Mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase (2010-06-08),

8. 7547535 - Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase (2009-06-16),

9. 7547524 - Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion (2009-06-16),

10. 7132270 - Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase (2006-11-07),

11. 6958231 - Variants of Erwinia-type creatinase (2005-10-25),

Peter Kratzsch: Innovator in Enzyme Detection and Mutant Biochemistry

Introduction

Peter Kratzsch is an accomplished inventor based in Penzberg, Germany, known for his significant contributions to the field of biochemistry and enzyme technology. With a total of 11 patents to his name, he has dedicated his career to developing innovative methods that enhance scientific understanding and applications of enzymes.

Latest Patents

Among his latest innovations, Kratzsch has developed an “Activity Assay for Bond Forming Enzymes,” which details a method for detecting sortase in a sample. This patent is pivotal for researchers working with enzyme applications. Additionally, he has invented a “Mutant 3-Hydroxybutyrate Dehydrogenase,” which showcases improved performance compared to its wild-type counterpart. This invention includes provisions for determining the concentration of 3-hydroxybutyrate in various samples, making it a valuable tool in biochemical research and applications.

Career Highlights

Throughout his career, Peter Kratzsch has worked extensively in prominent companies such as Roche Diagnostics Operations, Inc. and Roche Diabetes Care, Inc. His roles in these organizations have allowed him to refine his expertise in enzyme functionality and diagnostics, proving influential in shaping his inventive pursuits.

Collaborations

Kratzsch has collaborated with esteemed colleagues, including Mara Boenitz-Dulat and Rainer Schmuck. Their teamwork has fostered a creative environment that encourages innovation and the sharing of ideas, further propelling advancements in their field.

Conclusion

Peter Kratzsch exemplifies the innovative spirit of modern inventors, as shown by his impactful patents and significant contributions to biochemistry. His work continues to influence the understanding of enzyme mechanisms, paving the way for future scientific advancements.

This text is generated by artificial intelligence and may not be accurate.